Page last updated: 2024-08-26

imipenem, anhydrous and Leukemia, Pre-B-Cell

imipenem, anhydrous has been researched along with Leukemia, Pre-B-Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourdier, A; Haouy, S; Marchandin, H; Michon, AL; Saumet, L; Sirvent, N1
Demircioğlu, F; Oren, H1

Other Studies

2 other study(ies) available for imipenem, anhydrous and Leukemia, Pre-B-Cell

ArticleYear
Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:3

    Topics: Anti-Bacterial Agents; Bacteremia; Child; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Methylobacteriaceae; Mucous Membrane; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis

2014
Ecthyma gangrenosum: sign of Pseudomonas aeruginosa bacteremia.
    Pediatric hematology and oncology, 2008, Volume: 25, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Child; Ecthyma; Female; Humans; Imipenem; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections

2008